Biomarkers Market By Biomarker Type (Safety, Efficacy, and Validation), By Application (Diagnostic, Drug Discovery & Development, Personalized Medicine, and Others), and By Disease (Cancer, Cardiovascular Diseases, Neurological Diseases, Immunological Diseases, and Others)-Global Industry Analytics, COVID-19 Business Impact, and Trends, 2020–2029
- TBI589345
- July 24, 2020
- Global
- 132 pages
- SAC Insights
Abstract
The report covers a forecast and an analysis of the biomarkers market on a global and regional level. The study provides historical data from 2016 to 2018 along with a forecast from 2019 to 2025 based on revenue (USD Billion). The study includes the drivers and restraints of the biomarkers market along with their impact on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the biomarkers market on a global level.
In order to give the users a comprehensive view of the biomarkers market, we have included a competitive landscape and an analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein all the segments are benchmarked based on their market size, growth rate, and general attractiveness.
The report provides company market share analysis to give a broader overview of the key players in the market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new launch, agreements, partnerships, collaborations & joint ventures, research & development, technology, and regional expansion of major participants involved in the market on a global and regional basis.
The study provides a decisive view of the biomarkers market by segmenting it based on biomarker type, application, disease, and region. All the segments have been analyzed based on present and future trends and the market is estimated from 2019 to 2025. The regional segment includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.
Some key players in the global biomarkers market are Agilent Technologies, F. Hoffmann-La Roche, Epigenomics, Abbott, Thermo Fisher Scientific, Johnson & Johnson, Siemens Healthcare, Bio-Rad Laboratories, and Qiagen.
This report segments the global biomarkers market into:
Global Biomarkers Market: Biomarker Type Analysis
Safety Biomarkers
Efficacy Biomarkers
Validation Biomarkers
Global Biomarkers Market: Application Analysis
Diagnostic
Drug Discovery and Development
Personalized Medicine
Others
Global Biomarkers Market: Technology Analysis
Cancer
Cardiovascular Diseases
Neurological Diseases
Immunological Diseases
Others
Global Biomarkers Market: Regional Analysis
North America
The U.S.
Europe
UK
France
Germany
Asia Pacific
China
Japan
India
Latin America
Brazil
Middle East and Africa
Table of Contents
Request Table Of Content
Click To Request Sample
Chapter 1. Introduction
1.1. Report description and scope
1.2. Research scope
1.3. Research methodology
1.3.1. Market research process
1.3.2. Market research methodology
Chapter 2. Executive Summary
2.1. Global Biomarkers Market, 2016-2025 (USD Billion)
2.2. Global Biomarkers Market: Snapshot
Chapter 3. Biomarkers Market
| read more...
Related Reports
Global Biomass Charcoal Sales Data & Market Report 2020 and Forecast 2021-2026
Published : 21, January
Published : 21, January